1. Home
  2. BFC vs MPLT Comparison

BFC vs MPLT Comparison

Compare BFC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

N/A

Current Price

$153.63

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$13.06

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BFC
MPLT
Founded
1894
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
BFC
MPLT
Price
$153.63
$13.06
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$157.00
$32.67
AVG Volume (30 Days)
54.4K
568.5K
Earning Date
04-16-2026
05-28-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
82.39
EPS
3.99
N/A
Revenue
N/A
N/A
Revenue This Year
$58.67
N/A
Revenue Next Year
$2.01
N/A
P/E Ratio
$37.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$119.08
$9.10
52 Week High
$159.10
$40.43

Technical Indicators

Market Signals
Indicator
BFC
MPLT
Relative Strength Index (RSI) 53.23 39.69
Support Level $149.89 $12.24
Resistance Level $159.10 $20.20
Average True Range (ATR) 3.39 0.98
MACD -0.53 0.92
Stochastic Oscillator 52.09 75.51

Price Performance

Historical Comparison
BFC
MPLT

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: